No Data
No Data
9 Health Care Stocks Whale Activity In Today's Session
ImmunityBio's ANKTIVA Now Available To Patients Through Both Commercial And Government Insurance Programs, Also Announced Plans To Expand Its Bladder Cancer Program Globally, Notably In The European Union And India
Express News | Immunitybio: Received Regulatory Approval to Begin Patient Enrollment in Quilt-2.005 in India
Express News | Immunitybio Inc - Plans to Submit an Application to South Africa Regulatory Authorities in Q3 2024 to Initiate Quilt-2.005 Trial
Express News | Immunitybio Inc - Initial EMA Filing Anticipated in Q4 2024
Express News | Immunitybio Inc - Filing Process Initiated With EMA for Anktiva Approval
No Data